4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2%
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

4DMedical Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

4DMedical Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Other Current Liabilities
AU$17.1m
CAGR 3-Years
38%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Other Current Liabilities
AU$11.6m
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Other Current Liabilities
$3.8m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Other Current Liabilities
AU$32.3m
CAGR 3-Years
26%
CAGR 5-Years
20%
CAGR 10-Years
20%
Medibio Ltd
ASX:MEB
Other Current Liabilities
AU$131.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Other Current Liabilities
AU$24.4m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is 4DMedical Ltd's Other Current Liabilities?
Other Current Liabilities
17.1m AUD

Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Other Current Liabilities amounts to 17.1m AUD.

What is 4DMedical Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
75%

Over the last year, the Other Current Liabilities growth was 43%. The average annual Other Current Liabilities growth rates for 4DMedical Ltd have been 38% over the past three years , 75% over the past five years .

Back to Top